Anthony Florence Insider Profile

11 Followers
Anthony Florence, Ten Percent Owner at Arca Biopharma, holds 24.47M shares in Savara (Ticker: SVRA), holds 2.20M shares in Mirum Pharmaceuticals (Ticker: MIRM), holds 4.75M shares in Arcellx Inc (Ticker: ACLX). Most recently, Anthony Florence Bought ― shares of Savara on Jul 19, 2023 for an estimated value of 1000.00K.
tipranks
Anthony Florence

Anthony Florence
Arca Biopharma (ABIO)
Ten Percent Owner

Ranked #101,702 out of 105,137 Corporate Insiders

Profitable Transactions

27%
17 out of 62 Profitable Transactions

Average Return

-16.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2B
52.77%
11.35%
9.53%
7.91%
18.43% Others
A breakdown of Anthony Florence's holdings

Insider Roles

Bright Health Group
(BHG)
Ten Percent Owner
Robinhood Markets
(HOOD)
Director
IonQ
(IONQ)
Ten Percent Owner
Arcellx Inc
(ACLX)
Ten Percent Owner
+16 other positions
Roles that Anthony Florence holds in companies

Most Profitable Insider Trade

Stock:
Achaogen
(AKAOQ)
Rating:Informative Buy
Date:Jun 07, 2016 - Jun 07, 2017
Return:+423.70%
The most profitable trade made by Anthony Florence

Anthony Florence's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Arca Biopharma
Feb 27, 2018
Ten Percent Owner
Informative Sell
730.10K
$0.00
Adaptimmune Therapeutics
Jan 28, 2020
Ten Percent Owner
Informative Buy
4.95M
$80.14M
AVEO
AVEO Pharma
Oct 21, 2022
Uninformative Sell
$5.31K
AKAOQ
Achaogen
Dec 19, 2016
Informative Buy
6.75M
$117.88K
CASC
Cascadian Therapeutics
Mar 13, 2018
Uninformative Sell
$0.00
Regulus
May 09, 2019
Former 10% Owner
Informative Buy
1.23M
$2.63M
Appian
Feb 15, 2018
Ten Percent Owner
Uninformative Buy
$679.11K
Synlogic
Jan 26, 2018
Ten Percent Owner
Uninformative Buy
4.00M
$1.41M
SURF
Surface Oncology
Apr 23, 2018
Informative Buy
2.00M
$3.54M
MULE
Mulesoft Inc
May 09, 2018
Uninformative Sell
$0.00
Genocea Biosciences
May 26, 2022
Ten Percent Owner
Informative Sell
711.52K
$0.00
Trevi Therapeutics
Apr 13, 2022
Ten Percent Owner
Informative Buy
6.80M
$24.11M
Mirum Pharmaceuticals
Jun 15, 2023
Ten Percent Owner
Uninformative Buy
$67.52M
CSPR
Casper Sleep
Jun 14, 2021
Uninformative Buy
$42.41M
Mersana Therapeutics
Sep 16, 2020
Ten Percent Owner
Uninformative Buy
$7.59M
AKUS
AKOUOS
Dec 02, 2022
Uninformative Sell
$0.00
Nkarta
Jul 16, 2020
Ten Percent Owner
Uninformative Buy
$4.67M
Inozyme Pharma
Jul 28, 2020
Ten Percent Owner
Informative Buy
4.00M
$11.21M
MTCR
Metacrine
Dec 27, 2021
Informative Sell
493.91K
$1.49M
Eargo
May 26, 2021
Ten Percent Owner
Uninformative Sell
$10.08M
Bright Health Group
Jun 30, 2021
Ten Percent Owner
Uninformative Buy
$1.07B
Monte Rosa Therapeutics
Jun 30, 2021
Ten Percent Owner
Uninformative Buy
$46.15M
Robinhood Markets
May 04, 2022
Director
Uninformative Sell
$231.08M
IonQ
Nov 18, 2022
Ten Percent Owner
Uninformative Sell
$194.10M
Arcellx Inc
Dec 22, 2022
Ten Percent Owner
Uninformative Sell
$161.15M
Savara
Jul 19, 2023
Ten Percent Owner
Informative Buy
1000.00K
$92.50M
Ardelyx
Dec 09, 2019
Ten Percent Owner
Uninformative Buy
2.50M
$25.93M
TRACON Pharmaceuticals
Mar 27, 2018
Ten Percent Owner
Informative Buy
1.91M
$752.12K
LOXO
Loxo Oncology
Aug 06, 2014
Uninformative Buy
$419.91M
CRCM
Care
$0.00
List of latest transactions for each holding click on a transaction to see Anthony Florence's performance on stock

Anthony Florence insider profile FAQ

What is the percentage of profitable transactions made by Anthony Florence?
The percentage of profitable transactions made by Anthony Florence is 27%.
    What is the average return per transaction made by Anthony Florence?
    The average return per transaction made by Anthony Florence is -16.20%.
      What stocks does Anthony Florence hold?
      Anthony Florence holds: ABIO, ADAP, AVEO, AKAOQ, CASC, RGLS, APPN, SYBX, SURF, MULE, GNCAQ, TRVI, MIRM, CSPR, MRSN, AKUS, NKTX, INZY, MTCR, EAR, BHG, GLUE, HOOD, IONQ, ACLX, SVRA, ARDX, TCON, LOXO, CRCM stocks.
        What was Anthony Florence’s latest transaction?
        Anthony Florence latest transaction was an Informative Buy of $1000.00K.
          What was Anthony Florence's most profitable transaction?
          Anthony Florence’s most profitable transaction was an Informative Buy of AKAOQ stock on June 7, 2016. The return on the trade was 423.70%.
            What is Anthony Florence's role in Arca Biopharma?
            Anthony Florence's role in Arca Biopharma is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.